Lièvre A - Search Results

1

Chemotherapy versus self-expanding metal stent as primary treatment of severe dysphagia from unresectable oesophageal or gastro-oesophageal junction cancer.

Touchefeu Y, Archambeaud I, Landi B, Lièvre A, Lepère C, Rougier P, Mitry E. Touchefeu Y, et al. Among authors: lievre a. Dig Liver Dis. 2014 Mar;46(3):283-6. doi: 10.1016/j.dld.2013.10.012. Epub 2013 Nov 20. Dig Liver Dis. 2014. PMID: 24268567

2

[Chemotherapy for colorectal cancers].

Lièvre A, Mitry E. Lièvre A, et al. J Chir (Paris). 2003 Feb;140(1):52-5. J Chir (Paris). 2003. PMID: 12709655 Review. French.

3

Absence of mutation in the putative tumor-suppressor gene KLF6 in colorectal cancers.

Lièvre A, Landi B, Côté JF, Veyrie N, Zucman-Rossi J, Berger A, Laurent-Puig P. Lièvre A, et al. Oncogene. 2005 Nov 3;24(48):7253-6. doi: 10.1038/sj.onc.1208867. Oncogene. 2005. PMID: 16044160

4

[Detection of microsatellite instability in colorectal cancer].

Laurent-Puig P, Landi B, Lièvre A. Laurent-Puig P, et al. Among authors: lievre a. Gastroenterol Clin Biol. 2005 Jun-Jul;29(6-7):657-8. doi: 10.1016/s0399-8320(05)82152-9. Gastroenterol Clin Biol. 2005. PMID: 16141998 Free article. French. No abstract available.

5

KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancer.

Lièvre A, Bachet JB, Le Corre D, Boige V, Landi B, Emile JF, Côté JF, Tomasic G, Penna C, Ducreux M, Rougier P, Penault-Llorca F, Laurent-Puig P. Lièvre A, et al. Cancer Res. 2006 Apr 15;66(8):3992-5. doi: 10.1158/0008-5472.CAN-06-0191. Cancer Res. 2006. PMID: 16618717

6

Cetuximab efficacy in patients treated routinely in university hospitals.

Bachet JB, Afchain P, Fermanian C, Bouchahda M, Mitry E, Landi B, André T, Lièvre A, Louvet C, Aegerter P, Levi F, Rougier P. Bachet JB, et al. Among authors: lievre a. Gastroenterol Clin Biol. 2007 Nov;31(11):941-9. doi: 10.1016/s0399-8320(07)78302-1. Gastroenterol Clin Biol. 2007. PMID: 18166882 Free article.

7

Risk of venous thrombosis in patients with pancreatic adenocarcinoma.

Mitry E, Taleb-Fayad R, Deschamps A, Mansencal N, Lepère C, Declety G, Lièvre A, Vaillant JN, Lesur G, Cramer E, Dubourg O, Rougier P. Mitry E, et al. Among authors: lievre a. Gastroenterol Clin Biol. 2007 Dec;31(12):1139-42. doi: 10.1016/s0399-8320(07)78352-5. Gastroenterol Clin Biol. 2007. PMID: 18176374 Free article.

8

KRAS mutations as an independent prognostic factor in patients with advanced colorectal cancer treated with cetuximab.

Lièvre A, Bachet JB, Boige V, Cayre A, Le Corre D, Buc E, Ychou M, Bouché O, Landi B, Louvet C, André T, Bibeau F, Diebold MD, Rougier P, Ducreux M, Tomasic G, Emile JF, Penault-Llorca F, Laurent-Puig P. Lièvre A, et al. J Clin Oncol. 2008 Jan 20;26(3):374-9. doi: 10.1200/JCO.2007.12.5906. J Clin Oncol. 2008. PMID: 18202412

9

Isolated brainstem involvement in posterior reversible leukoencephalopathy induced by bevacizumab.

El Maalouf G, Mitry E, Lacout A, Lièvre A, Rougier P. El Maalouf G, et al. Among authors: lievre a. J Neurol. 2008 Feb;255(2):295-6. doi: 10.1007/s00415-008-0692-2. Epub 2008 Feb 20. J Neurol. 2008. PMID: 18283405 No abstract available.

10

[Antiangiogenic agents and gastrointestinal cancers].

Lièvre A, Landi B, Mitry E, Taïeb J. Lièvre A, et al. Gastroenterol Clin Biol. 2008 May;32(5 Pt 1):504-20. doi: 10.1016/j.gcb.2008.01.042. Epub 2008 May 8. Gastroenterol Clin Biol. 2008. PMID: 18472378 Free article. French.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

173 results

Search Page

Filters